{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:23:18Z","timestamp":1740172998515,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01935-y","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T04:03:17Z","timestamp":1666324997000},"page":"763-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas"],"prefix":"10.1007","volume":"46","author":[{"given":"L.","family":"di Filippo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Losa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Lena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mapelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Incampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-0702","authenticated-orcid":false,"given":"R.","family":"Lanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"1935_CR1","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J. WHO classification of tumours of endocrine organs. International Agency for Research on Cancer, January 2017. 978\u20139\u201328\u2013324493\u20136"},{"issue":"6","key":"1935_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","volume":"41","author":"M Sherlock","year":"2020","unstructured":"Sherlock M, Scarsbrook A, Abbas A et al (2020) Adrenal Incidentaloma. Endocr Rev 41(6):775\u2013820. https:\/\/doi.org\/10.1210\/endrev\/bnaa008","journal-title":"Endocr Rev"},{"issue":"16","key":"1935_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1056\/NEJMcp2031112","volume":"384","author":"E Kebebew","year":"2021","unstructured":"Kebebew E (2021) Adrenal Incidentaloma. N Engl J Med 384(16):1542\u20131551. https:\/\/doi.org\/10.1056\/NEJMcp2031112","journal-title":"N Engl J Med"},{"key":"1935_CR4","doi-asserted-by":"publisher","unstructured":"Papanicolas I, Woskie LR, Jha AK. Health Care Spending in the United States and Other High-Income Countries [published correction appears in JAMA. 2018 May 1;319(17 ):1824]. JAMA. 2018;319(10):1024\u20131039. https:\/\/doi.org\/10.1001\/jama.2018.1150","DOI":"10.1001\/jama.2018.1150"},{"key":"1935_CR5","doi-asserted-by":"publisher","unstructured":"Kebebew E. Management of adrenal masses in children and adults. Springer, Cham. 2017. https:\/\/doi.org\/10.1007\/978-3-319-44136-8","DOI":"10.1007\/978-3-319-44136-8"},{"key":"1935_CR6","doi-asserted-by":"publisher","unstructured":"Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356(6):601\u2013610. https:\/\/doi.org\/10.1056\/NEJMcp065470","DOI":"10.1056\/NEJMcp065470"},{"issue":"3","key":"1935_CR7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12020-022-02997-x","volume":"75","author":"G Incampo","year":"2022","unstructured":"Incampo G, Di Filippo L, Grossrubatscher EM et al (2022) Adrenal schwannoma: why should endocrinologists be aware of this uncommon tumour? Endocrine 75(3):684\u2013697. https:\/\/doi.org\/10.1007\/s12020-022-02997-x","journal-title":"Endocrine"},{"key":"1935_CR8","doi-asserted-by":"publisher","unstructured":"M\u00ednguez Ojeda C, G\u00f3mez Dos Santos V, \u00c1lvaro Lorca J, et al. Tumour size in adrenal tumours: its importance in the indication of adrenalectomy and in surgical outcomes-a single-centre experience [published online ahead of print, 2022 Jun 24]. J Endocrinol Invest. 2022;https:\/\/doi.org\/10.1007\/s40618-022-01836-0. https:\/\/doi.org\/10.1007\/s40618-022-01836-0","DOI":"10.1007\/s40618-022-01836-0 10.1007\/s40618-022-01836-0"},{"issue":"6018","key":"1935_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi M, Scholl UI, Yue P et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331(6018):768\u2013772. https:\/\/doi.org\/10.1126\/science.1198785","journal-title":"Science"},{"issue":"9","key":"1935_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EA Azizan","year":"2013","unstructured":"Azizan EA, Poulsen H, Tuluc P et al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45(9):1055\u20131060. https:\/\/doi.org\/10.1038\/ng.2716","journal-title":"Nat Genet"},{"issue":"11","key":"1935_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"Beuschlein F, Fassnacht M, Assi\u00e9 G et al (2014) Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N Engl J Med 370(11):1019\u20131028. https:\/\/doi.org\/10.1056\/NEJMoa1310359","journal-title":"N Engl J Med"},{"issue":"6186","key":"1935_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1126\/science.1249480","volume":"344","author":"Y Cao","year":"2014","unstructured":"Cao Y, He M, Gao Z et al (2014) Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome. Science 344(6186):913\u2013917. https:\/\/doi.org\/10.1126\/science.1249480","journal-title":"Science"},{"issue":"2","key":"1935_CR13","doi-asserted-by":"publisher","first-page":"E419","DOI":"10.1210\/jc.2010-1885","volume":"96","author":"S Bonnet","year":"2011","unstructured":"Bonnet S, Gaujoux S, Launay P et al (2011) Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. J Clin Endocrinol Metab 96(2):E419\u2013E426. https:\/\/doi.org\/10.1210\/jc.2010-1885","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"1935_CR14","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assi\u00e9","year":"2013","unstructured":"Assi\u00e9 G, Lib\u00e9 R, Espiard S et al (2013) ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome. N Engl J Med 369(22):2105\u20132114. https:\/\/doi.org\/10.1056\/NEJMoa1304603","journal-title":"N Engl J Med"},{"issue":"9","key":"1935_CR15","doi-asserted-by":"publisher","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","volume":"99","author":"L Gagliardi","year":"2014","unstructured":"Gagliardi L, Schreiber AW, Hahn CN et al (2014) ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 99(9):E1784\u2013E1792. https:\/\/doi.org\/10.1210\/jc.2014-1265","journal-title":"J Clin Endocrinol Metab"},{"key":"1935_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.coemr.2019.07.010","volume":"8","author":"CA Stratakis","year":"2019","unstructured":"Stratakis CA, Berthon A (2019) Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology. Curr Opin Endocr Metab Res 8:104\u2013111. https:\/\/doi.org\/10.1016\/j.coemr.2019.07.010","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"1","key":"1935_CR17","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.1210\/jc.2014-2648","volume":"100","author":"U Elbelt","year":"2015","unstructured":"Elbelt U, Trovato A, Kloth M et al (2015) Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. J Clin Endocrinol Metab 100(1):E119\u2013E128. https:\/\/doi.org\/10.1210\/jc.2014-2648","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1935_CR18","doi-asserted-by":"publisher","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","volume":"99","author":"GA Alencar","year":"2014","unstructured":"Alencar GA, Lerario AM, Nishi MY et al (2014) ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J Clin Endocrinol Metab 99(8):E1501\u2013E1509. https:\/\/doi.org\/10.1210\/jc.2013-4237","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1935_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1530\/EJE-15-0205","volume":"173","author":"R Correa","year":"2015","unstructured":"Correa R, Zilbermint M, Berthon A et al (2015) The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur J Endocrinol 173(4):435\u2013440. https:\/\/doi.org\/10.1530\/EJE-15-0205","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1935_CR20","doi-asserted-by":"publisher","first-page":"K7","DOI":"10.1530\/EJE-20-0014","volume":"183","author":"T Jojima","year":"2020","unstructured":"Jojima T, Kogai T, Iijima T et al (2020) Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report. Eur J Endocrinol 183(6):K7\u2013K12. https:\/\/doi.org\/10.1530\/EJE-20-0014","journal-title":"Eur J Endocrinol"},{"key":"1935_CR21","doi-asserted-by":"publisher","unstructured":"Ferreira MJ, Pedro J, Salazar D, et al. ARMC5 Primary Bilateral Macronodular Adrenal Hyperplasia Associated with a Meningioma: A Family Report. Case Rep Endocrinol. 2020;2020:8848151. Published 2020 Sep 2. https:\/\/doi.org\/10.1155\/2020\/8848151","DOI":"10.1155\/2020\/8848151"},{"key":"1935_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mce.2016.08.018","volume":"441","author":"A Berthon","year":"2017","unstructured":"Berthon A, Faucz F, Bertherat J, Stratakis CA (2017) Analysis of ARMC5 expression in human tissues. Mol Cell Endocrinol 441:140\u2013145. https:\/\/doi.org\/10.1016\/j.mce.2016.08.018","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1935_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1055\/s-2004-814582","volume":"36","author":"I Ilias","year":"2004","unstructured":"Ilias I, Alesci S, Pacak K (2004) Current views on imaging of adrenal tumors. Horm Metab Res 36(6):430\u2013435. https:\/\/doi.org\/10.1055\/s-2004-814582","journal-title":"Horm Metab Res"},{"issue":"2","key":"1935_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0720-048x(01)00444-2","volume":"41","author":"ME Lockhart","year":"2002","unstructured":"Lockhart ME, Smith JK, Kenney PJ (2002) Imaging of adrenal masses. Eur J Radiol 41(2):95\u2013112. https:\/\/doi.org\/10.1016\/s0720-048x(01)00444-2","journal-title":"Eur J Radiol"},{"issue":"12","key":"1935_CR25","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s40618-021-01615-3","volume":"44","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Barbot M, Scaroni C, Boscaro M (2021) Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J Endocrinol Invest 44(12):2749\u20132763. https:\/\/doi.org\/10.1007\/s40618-021-01615-3","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1935_CR26","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF03344099","volume":"29","author":"S Bovio","year":"2006","unstructured":"Bovio S, Cataldi A, Reimondo G et al (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29(4):298\u2013302","journal-title":"J Endocrinol Invest"},{"key":"1935_CR27","doi-asserted-by":"publisher","unstructured":"Mariani BMP, Nishi MY, Wanichi IQ, et al. Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules. Front Endocrinol (Lausanne). 2020;11:36. Published 2020 Feb 7. doi:https:\/\/doi.org\/10.3389\/fendo.2020.00036","DOI":"10.3389\/fendo.2020.00036"},{"issue":"1","key":"1935_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review J Neurosurg 122(1):4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"A RANO review J Neurosurg"},{"key":"1935_CR29","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015 [published correction appears in Neuro Oncol. 2018 Nov 17;:null]. Neuro Oncol. 2018;20(suppl_4):iv1-iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","DOI":"10.1093\/neuonc\/noy131"},{"issue":"12","key":"1935_CR30","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/neuonc\/nor120","volume":"13","author":"I Baldi","year":"2011","unstructured":"Baldi I, Gruber A, Alioum A et al (2011) Descriptive epidemiology of CNS tumors in France: results from the gironde registry for the period 2000\u20132007. Neuro Oncol 13(12):1370\u20131378. https:\/\/doi.org\/10.1093\/neuonc\/nor120","journal-title":"Neuro Oncol"},{"issue":"3","key":"1935_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307\u2013314. https:\/\/doi.org\/10.1007\/s11060-010-0386-3","journal-title":"J Neurooncol"},{"issue":"6","key":"1935_CR32","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/cncr.20088","volume":"100","author":"W Krampla","year":"2004","unstructured":"Krampla W, Newrkla S, Pfisterer W et al (2004) Frequency and risk factors for meningioma in clinically healthy 75-year-old patients: results of the Transdanube Ageing Study (VITA). Cancer 100(6):1208\u20131212. https:\/\/doi.org\/10.1002\/cncr.20088","journal-title":"Cancer"},{"issue":"18","key":"1935_CR33","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","volume":"357","author":"MW Vernooij","year":"2007","unstructured":"Vernooij MW, Ikram MA, Tanghe HL et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357(18):1821\u20131828. https:\/\/doi.org\/10.1056\/NEJMoa070972","journal-title":"N Engl J Med"},{"issue":"21","key":"1935_CR34","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2217\/fon-2018-0006","volume":"14","author":"RA Buerki","year":"2018","unstructured":"Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV (2018) An overview of meningiomas. Future Oncol 14(21):2161\u20132177. https:\/\/doi.org\/10.2217\/fon-2018-0006","journal-title":"Future Oncol"},{"key":"1935_CR35","unstructured":"WHO Classification of Tumours Editorial Board. Central Nervous System Tumours. International Agency for Research on Cancer, January 2021. 978\u20139\u201328\u2013324508\u20137"},{"key":"1935_CR36","doi-asserted-by":"publisher","unstructured":"Hage M, Plesa O, Lemaire I, Raffin Sanson ML. Estrogen and Progesterone Therapy and Meningiomas. Endocrinology. 2022;163(2):bqab259. https:\/\/doi.org\/10.1210\/endocr\/bqab259","DOI":"10.1210\/endocr\/bqab259"},{"issue":"2","key":"1935_CR37","first-page":"168","volume":"1","author":"H Cushing","year":"1929","unstructured":"Cushing H, Eisenhardt L (1929) Meningiomas arising from the tuberculum sellae: with the syndrome of primary optic atrophy and bitemporal field defects combined with a normal sella turcica in a middle-aged person. Acta Neuropathol 1(2):168\u2013206","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1935_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3171\/jns.1979.50.4.0499","volume":"50","author":"MS Donnell","year":"1979","unstructured":"Donnell MS, Meyer GA, Donegan WL (1979) Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50(4):499\u2013502. https:\/\/doi.org\/10.3171\/jns.1979.50.4.0499","journal-title":"J Neurosurg"},{"issue":"3","key":"1935_CR39","first-page":"193","volume":"136","author":"M Poisson","year":"1980","unstructured":"Poisson M, Magdelenat H, Foncin JF et al (1980) Estrogen and progestin receptors in meningiomas: a study in 22 cases [author\u2019s transl]. Rev Neurol (Paris) 136(3):193\u2013203","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"1935_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/annonc\/mdy010","volume":"29","author":"Z Du","year":"2018","unstructured":"Du Z, Santagata S (2018) Uncovering the links between systemic hormones and oncogenic signaling in the pathogenesis of meningioma. Ann Oncol 29(3):537\u2013540. https:\/\/doi.org\/10.1093\/annonc\/mdy010","journal-title":"Ann Oncol"},{"issue":"3","key":"1935_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/annonc\/mdx763","volume":"29","author":"M Peyre","year":"2018","unstructured":"Peyre M, Gaillard S, de Marcellus C et al (2018) Progestin-associated shift of meningioma mutational landscape. Ann Oncol 29(3):681\u2013686. https:\/\/doi.org\/10.1093\/annonc\/mdx763","journal-title":"Ann Oncol"},{"key":"1935_CR42","doi-asserted-by":"publisher","unstructured":"Portet S, Naoufal R, Tachon G, et al. Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment. Neurooncol Adv. 2019;1(1):vdz003. Published 2019 May 28. https:\/\/doi.org\/10.1093\/noajnl\/vdz003","DOI":"10.1093\/noajnl\/vdz003"},{"issue":"4","key":"1935_CR43","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF03345185","volume":"26","author":"E De Menis","year":"2003","unstructured":"De Menis E, Tulipano G, Villa S et al (2003) Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? J Endocrinol Invest 26(4):359\u2013363. https:\/\/doi.org\/10.1007\/BF03345185","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1935_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101515","volume":"35","author":"S Frara","year":"2021","unstructured":"Frara S, Allora A, di Filippo L et al (2021) Osteopathy in mild adrenal Cushing\u2019s syndrome and Cushing disease. Best Pract Res Clin Endocrinol Metab 35(2):101515. https:\/\/doi.org\/10.1016\/j.beem.2021.101515","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"1935_CR45","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s40618-021-01557-w","volume":"44","author":"MO Rodrigues","year":"2021","unstructured":"Rodrigues MO, Moraes AB, de Paula MP, Pereira VA, Le\u00e3o ATT, Vieira NL (2021) Adrenal incidentaloma as a novel independent predictive factor for periodontitis. J Endocrinol Invest 44(11):2455\u20132463. https:\/\/doi.org\/10.1007\/s40618-021-01557-w","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1935_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12020-014-0387-7","volume":"48","author":"S Yener","year":"2015","unstructured":"Yener S, Yilmaz H, Demir T, Secil M, Comlekci A (2015) DHEAS for the prediction of subclinical Cushing\u2019s syndrome: perplexing or advantageous? Endocrine 48(2):669\u2013676. https:\/\/doi.org\/10.1007\/s12020-014-0387-7","journal-title":"Endocrine"},{"issue":"3","key":"1935_CR47","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1210\/jc.2016-2718","volume":"102","author":"MC Dennedy","year":"2017","unstructured":"Dennedy MC, Annamalai AK, Prankerd-Smith O et al (2017) Low DHEAS: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas. J Clin Endocrinol Metab 102(3):786\u2013792. https:\/\/doi.org\/10.1210\/jc.2016-2718","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1935_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/a-1539-6442","volume":"53","author":"EP Winzinger","year":"2021","unstructured":"Winzinger EP, Jandikova H, Haase M et al (2021) DHEAS and differential blood counts as indirect signs of glucocorticoid excess in adrenal non-producing adenomas. Horm Metab Res 53(8):512\u2013519. https:\/\/doi.org\/10.1055\/a-1539-6442","journal-title":"Horm Metab Res"},{"issue":"3","key":"1935_CR49","doi-asserted-by":"publisher","first-page":"e1181","DOI":"10.1210\/clinem\/dgab751","volume":"107","author":"K Berke","year":"2022","unstructured":"Berke K, Constantinescu G, Masjkur J et al (2022) Plasma steroid profiling in patients with adrenal incidentaloma. J Clin Endocrinol Metab 107(3):e1181\u2013e1192. https:\/\/doi.org\/10.1210\/clinem\/dgab751","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T09:24:42Z","timestamp":1679045082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1935"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01935-y","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest. The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study\nprotocol complies with the 1964 Declaration of Helsinki and was approved by the Hospital Ethics Committee (protocol no.\n34\/int\/2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants and Animals"}},{"value":"A signed informed consent was obtained from all the patients participating in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}